UCLA's Jonsson Comprehensive Cancer Center : In the News : VIDEO: Dr. Antoni Ribas Talks Secondary Skin Cancers with BRAF Inhibitor Zelboraf and How They Can Be Prevented

News Review

VIDEO: Dr. Antoni Ribas Talks Secondary Skin Cancers with BRAF Inhibitor Zelboraf and How They Can Be Prevented

Posted Date: 2/7/2012 10:45 AM

In this 10-minute video interview, watch UCLA Jonsson Comprehensive Cancer Center scientist Dr. Antoni Ribas discuss recent research findings that are aiding in the development of new treatments for advanced squamous cell carcinoma. He also explains how MEK inhibitor drugs are now being used in clinical trials. (From CurrentMedicine.tv)

Watch the video.

Save/Share